Optical Imaging of Skin Cancers for Margin Delineation of Non-Melanoma Skin Cancers

Completed · Not applicable

Conditions studied: Skin Cancer

In brief

The goal of this clinical research study is to evaluate an experimental imaging technology, the multispectral digital microscope (MDM), which may help doctors see how far skin cancer extends (widens out) on an area of skin. Researchers want to learn if this new technology can help doctors identify the exact areas involved in precancerous or cancerous changes in the skin.

Key facts

Study ID

NCT00432471

Run by

M.D. Anderson Cancer Center

People needed

23

Starts

2007-01-30

Expected to finish

2017-06-25

Last updated by the study team

2017-06-28

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who will be undergoing surgery to remove a region of skin suspected of containing non-melanoma skin cancer will be eligible to participate in this study. The proposed resection should be equal or greater than 1 cm in diameter.
• In addition, patients undergoing induction chemotherapy or biologic therapy prior to surgical resection are also eligible.
• Patients must sign an informed consent indicating awareness of the investigational nature of this study.

You may not qualify if…

• Patients with non-melanoma skin cancer lesion at eyelid, or in case that the lesion extends to superior or inferior eyelid, this area will not be imaged.
• Persons who are medically unfit to undergo resection of skin lesions.
• Persons under the age of 18.

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.